share_log

West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.

West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.

West Pharmaceutical Services的股票在瑞士銀行將其評級從中立上調至買入,並將目標價從350美元提高至390美元后交易上漲。
Benzinga ·  2024/12/13 03:26

West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.

West Pharmaceutical Services的股票在瑞士銀行將其評級從中立上調至買入,並將目標價從350美元提高至390美元后交易上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論